354
Views
3
CrossRef citations to date
0
Altmetric
Research Articles

Insights into the potential of withanolides as Phosphodiesterase-4 (PDE4D) inhibitors

, &
Pages 2108-2117 | Received 16 Nov 2021, Accepted 07 Jan 2022, Published online: 21 Jan 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Roshny Prasad, Harikrishnan Ajith, Naveen Kumar Chandrakumaran, Pawan Dnyaneshwar Khangar, Anand Mohan & Shijulal Nelson-Sathi. (2023) In silico study identifies peptide inhibitors that negate the effect of non-synonymous mutations in major drug targets of SARS-CoV-2 variants. Journal of Biomolecular Structure and Dynamics 41:19, pages 9551-9561.
Read now
Alhanouf I. Al-Harbi, Asad Ullah, Taghreed N. Almanaa, Farah Gul, Saifullah Khan, Yasir Waheed, Mahboob Ul Haq, Riaz Muhammad, Muhammad Khurram, Ameen Ullah & Sajjad Ahmad. (2023) A chemoinformatic-biophysics based approach to identify novel anti-virulent compounds against Pseudomonas aeruginosa disulfide-bond protein A1. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-10.
Read now

Articles from other publishers (1)

Jianwen Sheng, Shanjin Zhang, Lule Wu, Gajendra Kumar, Yuanhang Liao, Pratap GK & Huizhen Fan. (2022) Inhibition of phosphodiesterase: A novel therapeutic target for the treatment of mild cognitive impairment and Alzheimer’s disease. Frontiers in Aging Neuroscience 14.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.